Weill Medical College of Cornell University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Weill Medical College of Cornell University sits in the top decile of US sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count).
Weill Medical College of Cornell University: 701 sponsored US clinical trials, 127 recruiting.
Weill Medical College of Cornell University sponsors 701 registered US clinical trials on ClinicalTrials.gov, 127 of them currently recruiting, and 387 completed. 89 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 20 trials.
Top-decile sponsor footprint
Weill Medical College of Cornell University ranks in the top decile of sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
387 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
701 total, page 11 of 15
Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma
NCT01147393
Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy
NCT01537549
Analysis of Donor Biopsy Tissue Samples at the Time of Kidney Transplant
NCT01271465
Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory Diffuse Large b Cell Lymphoma (DLBCL)
NCT01120834
Use of ROTEM® in Pediatric Cardiac Surgical Patients
NCT01212289
Trial of PD 0332991 Plus Bortezomib in Patients With Relapsed Mantle Cell Lymphoma
NCT01111188
Safety Study of a Gene Transfer Vector (Rh.10) for Children With Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL)
NCT01161576
Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma
NCT01159574
Stress Level and the Relationship With IVF Outcomes.
NCT02638662
Aortic Wall and Left Ventricular Mechanics: Echocardiographic and Hemodynamic Analysis
NCT01236313
Marcaine Use in Laparoscopic Gynecological Surgery
NCT01861665
Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma
NCT00907413
AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis
NCT01414985
Shared Decision-Making for Elderly Depressed Primary Care Patients
NCT01031134
Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer
NCT01303159
An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia
NCT00605319
Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell Lymphoma
NCT01004991
Trial Using Motivational Interviewing Positive Affect and Self-Affirmation in Hypertension (TRIUMPH)
NCT01024933
RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF
NCT01035099
SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)
NCT01083667
Nebivolol Versus Metoprolol: Comparative Effects on Fatigue and Quality of Life
NCT00999102
SCALE: Small Changes and Lasting Effects
NCT01198990
Autologous Endometrial Coculture (AECCT)
NCT01472861
Treatment for Depressed Primary Care Patients
NCT01014312
The Natural History of Gene Expression in the Lung Cells of Non-Smokers, Smokers and Ex-Smokers in Health and Disease
NCT00974064
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
NCT00967577
A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)
NCT00875693
Genotype-Phenotype Correlations of Late Infantile Neuronal Ceroid Lipofuscinosis
NCT01035424
Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction
NCT01220726
Oocyte Cryopreservation
NCT01696786
A Study to Evaluate the Safety and Efficacy of Dasatinib (Sprycel) in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
NCT00918463
Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients
NCT00909363
Ecosystem Focused Therapy for Treating Older Depressed Stroke Survivors
NCT00944762
Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer
NCT00916123
Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy
NCT01174095
Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma
NCT00916058
Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea
NCT00859950
Use of ROTEM for Multi-level Spine Surgery
NCT00839995
Intraoperative Blood Pressure and Cognitive Performance
NCT00827385
Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)
NCT00902018
Evaluating the Impact on Quality and Costs of Regional Clinical Data Exchange Programs in New York State
NCT00571376
Efficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patients With Myelodysplastic Syndromes
NCT00840827
Effects of Coenzyme Q10 (CoQ) in Parkinson Disease
NCT00740714
The Effect of Intravenous Anesthetics on Fear Learning and Memory
NCT00767767
Pilot Study of Abbreviated Chemotherapy Based on Positron Emission Tomography (PET) Scan in Hodgkin's Lymphoma
NCT00901303
Impact of Vendor Systems on Ambulatory Medication Safety
NCT00773500
A New View of Normal Tension Glaucoma: Autoregulation and Systemic Blood Pressure
NCT00706056
A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer
NCT00760604
Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
NCT01244711
The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels
NCT01385709
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 111 |
| Phase 3 | 26 |
| Phase 4 | 63 |
Therapeutic Areas
What is open in the Weill Medical College of Cornell University pipeline
127 recruiting of 701 indexed (18% open); 387 completed (55%).
Phase mix: 89 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Weill Medical College of Cornell University: open-pipeline peers nationwide
Peers matched on 701 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Weill Medical College of Cornell University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 701 trials (± recruiting share)
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Sanofi · 713 trials · 10% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- Burke Medical Research Institute · 18% recruiting · 11 trials
- Grand Valley State University · 18% recruiting · 11 trials
Related
What to do with this Weill Medical College of Cornell University page
701 registered trials is a research-attention snapshot, not an endorsement of Weill Medical College of Cornell University or any single study.
- 127 of Weill Medical College of Cornell University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Weill Medical College of Cornell University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Weill Medical College of Cornell University pipeline card: 701 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.